Regenerex Pharma (RGPX) Cash from Investing Activities (2011 - 2023)
Regenerex Pharma (RGPX) reported Cash from Investing Activities of -$2670.0 for Q3 2023, up 26.43% on a QoQ basis from -$3629.0 in Q2 2023.
Regenerex Pharma (RGPX) has 4 years of Cash from Investing Activities data on file, last reported at -$2670.0 in Q3 2023.
- Quarterly Cash from Investing Activities changed N/A year-over-year to -$2670.0 in Q3 2023, while the trailing twelve-month figure through Mar 2024 was -$6299.0 (down 109.97% YoY) and the FY2025 annual result came in at -$1228.0, up 80.5% from the prior year.
- Cash from Investing Activities climbed to -$2670.0 in Q3 2023 per RGPX's latest filing, from -$3629.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$2670.0 in Q3 2023 and bottomed at -$3629.0 in Q2 2023.
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -2,670.00 |
| Sep 30, 2023 | -2,670.00 |
| Jun 30, 2023 | -3,629.00 |
| Jun 30, 2023 | -3,629.00 |
| Dec 31, 2021 | -3,000.00 |
| Dec 31, 2021 | -3,000.00 |
| Jun 30, 2017 | -16,000.00 |
| Jun 30, 2017 | -16,000.00 |
| Aug 31, 2011 | -375,000.00 |
| Aug 31, 2011 | -375,000.00 |